Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies is a research paper published in Oncotarget (2017). On theSindex it has a DataRank of 2.3. It has been cited 80 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.659
From this paper's citation signal
Citation Network Contribution
1.6
From 2 citing papers with measurable signal
National Institutes of Health
Grant: 5R01CA187457-04
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer
National Institutes of Health
Grant: 3P50CA070907-02S1
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER
National Institutes of Health
Grant: 5R01CA207295-05
Therapeutic strategies for targeting PARP1 in small cell lung cancer
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R01CA207295-09
DNA damaging therapy and immune response in small cell lung cancer subtypes
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R01 CA187457
NCRR NIH HHS
Grant: C06 RR020092
NCI NIH HHS
Grant: R01 CA207295
NCI NIH HHS
Grant: P50 CA070907
FWCI
4.08
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals